US Edition
New blood cancer drug shows promising results in global trial
Summary by Monash Health
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
New blood cancer drug shows promising results in global trial
Left to right: Laura Spence, Sarah Thorne, Farah Ansari, Dr Allison Mo, Kylie Rushford, and Daniel Trakman. A groundbreaking international study has revealed that a new drug, luspatercept, significantly outperforms the current standard treatment for anaemia in patients with lower-risk myelodysplastic syndromes (MDS). The COMMANDS trial analysed the difference between the drugs luspatercept and epoetin alfa, which is the current standard treatme…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
